Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
8.88
-0.34 (-3.69%)
At close: Mar 28, 2025, 4:00 PM
9.45
+0.57 (6.42%)
After-hours: Mar 28, 2025, 6:06 PM EDT
Myriad Genetics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 21.37, with a low estimate of 11 and a high estimate of 35. The average target predicts an increase of 140.65% from the current stock price of 8.88.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Myriad Genetics stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Buy | 4 | 4 | 2 | 2 | 3 | 4 |
| Hold | 4 | 4 | 6 | 6 | 6 | 6 |
| Sell | 2 | 2 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 12 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $12 → $13 | Hold → Buy | Upgrades | $12 → $13 | +40.77% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +29.50% | Mar 4, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $13 → $11 | Sell | Maintains | $13 → $11 | +23.87% | Mar 3, 2025 |
| Raymond James | Raymond James | Buy Reiterates $27 → $19 | Buy | Reiterates | $27 → $19 | +113.96% | Feb 25, 2025 |
| UBS | UBS | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +80.18% | Feb 25, 2025 |
Financial Forecast
Revenue This Year
862.48M
from 837.60M
Increased by 2.97%
Revenue Next Year
934.67M
from 862.48M
Increased by 8.37%
EPS This Year
0.07
from -1.41
EPS Next Year
0.29
from 0.07
Increased by 309.55%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 899.0M | 986.7M | 1.1B | ||
| Avg | 862.5M | 934.7M | 1.0B | ||
| Low | 803.8M | 833.3M | 865.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.3% | 14.4% | 21.3% | ||
| Avg | 3.0% | 8.4% | 8.6% | ||
| Low | -4.0% | -3.4% | -7.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.11 | 0.43 | 0.74 | ||
| Avg | 0.07 | 0.29 | 0.48 | ||
| Low | -0.08 | 0.14 | 0.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 515.5% | 156.6% | ||
| Avg | - | 309.6% | 69.1% | ||
| Low | - | 96.2% | 2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.